<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Neurology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82321AD2-CD2E-456C-9395-59CF155A3EC8"><gtr:id>82321AD2-CD2E-456C-9395-59CF155A3EC8</gtr:id><gtr:name>Sanofi</gtr:name><gtr:address><gtr:line1>174 avenue de France</gtr:line1><gtr:line4>Paris cedex 13</gtr:line4><gtr:postCode>75635</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/147A4A54-6D76-463F-99BD-C21F5AB451A4"><gtr:id>147A4A54-6D76-463F-99BD-C21F5AB451A4</gtr:id><gtr:firstName>Alastair</gtr:firstName><gtr:surname>Compston</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7A228825-29AE-4056-98F4-B70F9309B430"><gtr:id>7A228825-29AE-4056-98F4-B70F9309B430</gtr:id><gtr:firstName>James</gtr:firstName><gtr:surname>Fawcett</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9828345"><gtr:id>55AAEBDA-0A6F-427C-BD52-C7064F8A0514</gtr:id><gtr:title>Brain Repair</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9828345</gtr:grantReference><gtr:abstractText>The Cooperative in Brain Repair has used MRC funding for four posts to provide the infrastructure that has brought together 16 research groups to form a research centre with a critical mass of scientists working in the field of Brain Repair. The aim of the Cooperative is to develop treatments for chronic and crippling diseases of the nervous system. At present, when the brain or spinal cord are damaged, no repair takes place. This means that patients who suffering stroke, head injury, spinal cord injury, multiple sclerosis, or progressive damage through Parkinson?s disease, Alzheimer?s disease or other conditions do not regain full neurological function. Many of these patients live for many years. The science of Brain Repair, which has sprung from developmental biology, is starting to develop treatments that can repair some of this hitherto permanent damage to the nervous system. In the coming years these treatments will revolutionise the practice of neurology, and the lives of those with chronic neurological damage.</gtr:abstractText><gtr:technicalSummary>The main target diseases of the Cooperative are: 

Neurodegenerative disease Parkinson?s disease (PD)
 Huntington?s disease (HD)
 Dementias affecting the cortex and subcortical regions
 Alzheimers disease (AD)

Demyelinating disease Multiple Sclerosis (MS)
 Congenital disorders

Acute CNS damage Spinal Cord Injury (SCI)
 Head Injury
 Stroke

To develop treatments for these diseases the Cooperative will continue to conduct research into the following basic technologies:

1. Mechanisms of cell death, neurodegeneration and the development of neuroprotective
 treatments
2. Mechanisms of axon degeneration and axon protection
3. Stem cell and precursor pathology
4. Axon regeneration
5. Plasticity
6. Stem cell biology
7. Remyelination
8. Neuronal transplantation
9. Biomarkers of disease
10. Clinical applications</gtr:technicalSummary><gtr:fund><gtr:end>2010-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1794382</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanofi</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Genzyme Corporation</gtr:department><gtr:description>clinical</gtr:description><gtr:id>E0F13855-985B-409B-B50F-153136680B96</gtr:id><gtr:impact>International phase 3 trail for prevention of multiple sclerosis Establishment of different patterns of Parkinsons disease International consortium for transplantation in Parkinson's Embryonic transplants for Huntington's</gtr:impact><gtr:outcomeId>428C9A9C038-1</gtr:outcomeId><gtr:partnerContribution>Mutinational groups to develop treatments for MS, PD, HD</gtr:partnerContribution><gtr:piContribution>Suppression of immune system for prevention of multiple sclerosis Parkinsons clinic of incident patients Huntington's clinic</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Many audiences</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1BE31361-2279-4CEF-B5F6-C344511C3365</gtr:id><gtr:impact>Many appearances by members of the consortium on radio, TV, patient groups, schools, general public

Awareness of progress</gtr:impact><gtr:outcomeId>A3BEA769247</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Chondroitinase promotes plasticity and recovery after spinal cord injury</gtr:description><gtr:grantRef>G9828345</gtr:grantRef><gtr:id>D2D25996-47D8-455C-8E97-C797C7D72B26</gtr:id><gtr:impact>Progression towards clinical trials</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>3611377B958</gtr:outcomeId><gtr:patentId>JP2010132682</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>chondroitinase in spinal cord injury</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Transfection with alpha9 integrin promotes axon regeneration</gtr:description><gtr:grantRef>G9828345</gtr:grantRef><gtr:id>7C35AEC0-B1EF-42DA-97AD-65AE67C735B8</gtr:id><gtr:impact>none yet</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>002FB9056C5</gtr:outcomeId><gtr:patentId>WO2007083133</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Alpha9 integrin in axon regeneration</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>A microchannel regenerative nerve prosthesis for peripheral nerve repair and recording</gtr:description><gtr:grantRef>G9828345</gtr:grantRef><gtr:id>AD61977A-DAD2-40C8-B610-EA6EE2C9DE84</gtr:id><gtr:impact>A new concept in nerve repair</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>12E8C560E9E</gtr:outcomeId><gtr:patentId>WO2009090398</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Microchannel prosthesis for nerve repair</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>reviews</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>C81333BC-A52A-4645-90FA-19805268657E</gtr:id><gtr:impact>Advancing treatment of neurological conditions</gtr:impact><gtr:outcomeId>AABF810AFAC</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>guidelines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Guidelines in spinal cord injury, multiple sclerosis, Parkinsons</gtr:guidelineTitle><gtr:id>9F2A9208-30C1-43A1-B15D-BB2A28EE419D</gtr:id><gtr:impact>Improved clinical trials methodology</gtr:impact><gtr:outcomeId>4EB2079AE35</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Various biomarkers for Parkinson's, including motor tasks, eye movement tasks, cognitive assessment</gtr:description><gtr:id>3482D781-498A-42C8-BA3B-AEAC41C0B735</gtr:id><gtr:impact>Improved staging of Parkinsons</gtr:impact><gtr:outcomeId>9DC697BF12C</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>PD tests</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>A new regenerative microchannel interface for nerve repair</gtr:description><gtr:id>D1888F3D-BD49-4CAE-A190-9FB60EDBAA7D</gtr:id><gtr:impact>still in development</gtr:impact><gtr:outcomeId>83B1283B0AF</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>interface</gtr:title><gtr:type>Therapeutic Intervention - Cellular and gene therapies</gtr:type><gtr:yearDevCompleted>2008</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Clinics in Parkinson's, Huntington's , MS, stroke</gtr:description><gtr:id>A659485D-E031-48E8-8D05-BD8B7BF4C97D</gtr:id><gtr:impact>Improved understanding of disease progression and treatment</gtr:impact><gtr:outcomeId>26560B98FC1</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>clinical database</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>299AE0B1-6B48-47CD-A7D8-45E57ADE9FF7</gtr:id><gtr:title>Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76db304c22229075b07a33e8932b79de"><gtr:id>76db304c22229075b07a33e8932b79de</gtr:id><gtr:otherNames>Andrews MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>Wb7TUWashQr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>062E44E2-1202-4E2E-923C-7B6DC90C9909</gtr:id><gtr:title>The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system.</gtr:title><gtr:parentPublicationTitle>Brain research reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/833bd1666f1d6dcd1102923c18580d34"><gtr:id>833bd1666f1d6dcd1102923c18580d34</gtr:id><gtr:otherNames>Galtrey CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0165-0173</gtr:issn><gtr:outcomeId>69701CFEC2B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1669CC09-3803-4FC6-9542-DBC38485C9FB</gtr:id><gtr:title>Remyelination in the CNS: from biology to therapy.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d469ddfcd9562b3972ffe34f974f7d21"><gtr:id>d469ddfcd9562b3972ffe34f974f7d21</gtr:id><gtr:otherNames>Franklin RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-003X</gtr:issn><gtr:outcomeId>0093B3BFA99</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8139B54-4F28-44DC-88E5-680DE4B9D2AC</gtr:id><gtr:title>Damage control in the nervous system: rehabilitation in a plastic environment.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66f31baabd7a7106fade59ccf79e8e5d"><gtr:id>66f31baabd7a7106fade59ccf79e8e5d</gtr:id><gtr:otherNames>Fawcett JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>2F4AB9CA580</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>339B8B6B-B99B-4494-B683-19E075E9C880</gtr:id><gtr:title>The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d06efa5d9567e3b92f07af72467511d8"><gtr:id>d06efa5d9567e3b92f07af72467511d8</gtr:id><gtr:otherNames>Williams-Gray CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>EWC5uNAU4mK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FC195B2-D4F0-4C20-A8E6-A807DD80DA1B</gtr:id><gtr:title>Genome-wide and fine-resolution association analysis of malaria in West Africa.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f21f1d98cd7f57fabc7b6af7b890e47"><gtr:id>5f21f1d98cd7f57fabc7b6af7b890e47</gtr:id><gtr:otherNames>Jallow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>bMtZF8sDLku</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>639A0410-C630-4200-86F3-2497DB5D547A</gtr:id><gtr:title>Molecular control of brain plasticity and repair.</gtr:title><gtr:parentPublicationTitle>Progress in brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b23393912c1f6263eabb5a24c76c3419"><gtr:id>b23393912c1f6263eabb5a24c76c3419</gtr:id><gtr:otherNames>Fawcett J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0079-6123</gtr:issn><gtr:outcomeId>5BE30C353EC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F82C0126-6E8C-4F55-BA89-EBAC732E8170</gtr:id><gtr:title>Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d3f066faae75e37a2caa4255313f4bc"><gtr:id>3d3f066faae75e37a2caa4255313f4bc</gtr:id><gtr:otherNames>Garc?a-Al?as G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>hdBhMyVziXc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F7CED51-A879-4D6C-BA0D-C05D222DDB04</gtr:id><gtr:title>Common variants near MC4R are associated with fat mass, weight and risk of obesity.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f85b98982852df462ea3285f6431bafd"><gtr:id>f85b98982852df462ea3285f6431bafd</gtr:id><gtr:otherNames>Loos RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>riqvriQpp1W</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CF35993-6F4B-42D0-983A-1EB7332CF6C7</gtr:id><gtr:title>Stem cells, progenitors and myelin repair.</gtr:title><gtr:parentPublicationTitle>Journal of anatomy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcd2f88320855c9e0c59074101de3d8e"><gtr:id>dcd2f88320855c9e0c59074101de3d8e</gtr:id><gtr:otherNames>Zhao C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-8782</gtr:issn><gtr:outcomeId>46B31A7F0A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08AA448B-219A-473C-B595-02F2204BBCFC</gtr:id><gtr:title>Cell therapy in Huntington disease.</gtr:title><gtr:parentPublicationTitle>Neurosurgical focus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25dd0c30c65521f07ce0a58651e51281"><gtr:id>25dd0c30c65521f07ce0a58651e51281</gtr:id><gtr:otherNames>Clelland CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1092-0684</gtr:issn><gtr:outcomeId>D6F7CB070EB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7073DB2-BCBF-4D50-BEA4-DAA727A5CDEA</gtr:id><gtr:title>Origins of gliogenic stem cell populations within adult skin and bone marrow.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38b70905c1f3a957902e8ffb9af75a31"><gtr:id>38b70905c1f3a957902e8ffb9af75a31</gtr:id><gtr:otherNames>Hunt DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>fAvqtEEkdwF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D887D189-2B06-4029-9B64-7BF201534B5F</gtr:id><gtr:title>Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ca2394daf39676f0f8e86474665cff7"><gtr:id>1ca2394daf39676f0f8e86474665cff7</gtr:id><gtr:otherNames>Anderson JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>kxjPPowLZmZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA8E95FB-D472-4C42-9E4A-A37E0306BDEF</gtr:id><gtr:title>The future of cell therapies in the treatment of Parkinson's disease</gtr:title><gtr:parentPublicationTitle>EXPERT OPINION ON BIOLOGICAL THERAPY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9342b00fd151ead145bc296feeea0aa5"><gtr:id>9342b00fd151ead145bc296feeea0aa5</gtr:id><gtr:otherNames>Goy Rocio Laguna</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-2598</gtr:issn><gtr:outcomeId>5a360526e7dfe0.75023303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D5CADA7-8DBD-4D52-B149-0955D8545504</gtr:id><gtr:title>The future challenges in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5569c761d204c6033a9730736dccfe4c"><gtr:id>5569c761d204c6033a9730736dccfe4c</gtr:id><gtr:otherNames>Barker RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>DFA44B3AFBD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0F558AF-4146-4B1A-B3FC-760250C14082</gtr:id><gtr:title>Endogenous or exogenous oligodendrocytes for remyelination.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b66d0faee9b47a9c4f49c75e32e33088"><gtr:id>b66d0faee9b47a9c4f49c75e32e33088</gtr:id><gtr:otherNames>Blakemore WF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>B79613958EE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB93C4B2-3ABB-46F7-BCEF-3C479ACEC248</gtr:id><gtr:title>Astrocyte-produced ephrins inhibit schwann cell migration via VAV2 signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4417d5eae76735abd8c72172da3a9523"><gtr:id>4417d5eae76735abd8c72172da3a9523</gtr:id><gtr:otherNames>Afshari FT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>KR6sfPRxfUf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>242FF450-598B-4322-B9B6-18DFE6FF0D6E</gtr:id><gtr:title>The future of cell therapies in the treatment of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Expert opinion on biological therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3a9a15288794bad906cf39c99ee43ce"><gtr:id>c3a9a15288794bad906cf39c99ee43ce</gtr:id><gtr:otherNames>Laguna Goya R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-2598</gtr:issn><gtr:outcomeId>C6243A18CAA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>158DC99D-C6A6-43B0-A80D-F615B3CFBC33</gtr:id><gtr:title>Integrins: versatile integrators of extracellular signals.</gtr:title><gtr:parentPublicationTitle>Trends in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2ec2115ae283855b097341de4c67764"><gtr:id>f2ec2115ae283855b097341de4c67764</gtr:id><gtr:otherNames>ffrench-Constant C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0962-8924</gtr:issn><gtr:outcomeId>F089428D34A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1BAC69E-EA08-4FEB-AE5B-CFE6A93F9E32</gtr:id><gtr:title>Introduction: stem cells and brain repair.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/831cef59561581891915c23533bdd156"><gtr:id>831cef59561581891915c23533bdd156</gtr:id><gtr:otherNames>Chandran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>D16727FDDE0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AE3542D-3F61-4279-9162-2F1850AC233F</gtr:id><gtr:title>Human embryonic stem cells: an experimental and therapeutic resource for neurological disease.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fb120c58a3a06207c156f6b551ad790"><gtr:id>9fb120c58a3a06207c156f6b551ad790</gtr:id><gtr:otherNames>Joannides AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>FD2A6323505</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DDC19DC-376C-4EED-A74E-3DF4541DF7CF</gtr:id><gtr:title>Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials.</gtr:title><gtr:parentPublicationTitle>Spinal cord</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66f31baabd7a7106fade59ccf79e8e5d"><gtr:id>66f31baabd7a7106fade59ccf79e8e5d</gtr:id><gtr:otherNames>Fawcett JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1362-4393</gtr:issn><gtr:outcomeId>28728514360</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9828345</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>80</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>7EE9741E-CF94-420A-B0AB-A7811523CF2C</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Skin</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>